播放中国国产国语纯一级黄片免费看, 大鸡吧快来啊阿啊阿啊黄片在线播放, 中文精品日韩网站在线观看视频免费, 别揉我奶头~嗯~啊~一区二区三区,AV无码播放一级毛片免费古装,亚洲春色一区二区三区,91大神极品,美国一级大黄一片免费下载,午夜爽爽爽男女免费观看软件

Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-Amino-1-N-methylindole, with the chemical formula C9H10N2, is an indole derivative and a valuable building block in organic synthesis. It is characterized by a brown solid appearance and possesses a unique molecular structure that includes an amino group and a methylindole moiety. 5-AMINO-1-N-METHYLINDOLE is known for its role in the synthesis of various organic compounds, particularly in the copper-catalyzed synthesis of sulfonamides.

102308-97-4

Post Buying Request

102308-97-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

102308-97-4 Usage

Uses

Used in Pharmaceutical Industry:
5-Amino-1-N-methylindole is used as a key intermediate in the synthesis of sulfonamides, which are a class of antimicrobial agents. These sulfonamides are employed as antibiotics to treat a wide range of bacterial infections, including urinary tract infections, respiratory infections, and skin infections. The copper-catalyzed synthesis of sulfonamides using 5-Amino-1-N-methylindole allows for the development of new and more effective antimicrobial agents.
Used in Organic Synthesis:
5-Amino-1-N-methylindole is used as a versatile building block in organic synthesis for the preparation of various organic compounds. Its unique molecular structure allows for the formation of a wide range of chemical reactions, enabling the synthesis of complex organic molecules with potential applications in various fields, such as pharmaceuticals, agrochemicals, and materials science.
Used in Research and Development:
5-Amino-1-N-methylindole is used as a research compound in the development of new synthetic methods and reaction pathways. Its reactivity and structural features make it an attractive candidate for exploring novel synthetic routes and understanding the underlying mechanisms of various chemical reactions. This research can lead to the discovery of new synthetic strategies and the development of more efficient and environmentally friendly processes in the field of organic chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 102308-97-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,3,0 and 8 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 102308-97:
(8*1)+(7*0)+(6*2)+(5*3)+(4*0)+(3*8)+(2*9)+(1*7)=84
84 % 10 = 4
So 102308-97-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H10N2/c1-11-5-4-7-6-8(10)2-3-9(7)11/h2-6H,10H2,1H3

102308-97-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Methyl-1H-indol-5-amine

1.2 Other means of identification

Product number -
Other names 5-Amino-1-N-Methylindole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:102308-97-4 SDS

102308-97-4Relevant articles and documents

Novel anellated pyrazoloquinolin-3-ones: Synthesis and in vitro BZR activity

Ferlin, Maria Grazia,Chiarelotto, Gianfranco,Dall'Acqua, Stefano,MacIocco, Elisabetta,Mascia, Maria Paola,Pisu, Maria Giuseppina,Biggio, Giovanni

, p. 3531 - 3541 (2005)

A series of pyrazolo[4,3-c]pyrrolo[3,2-f]quinolin-3-one derivatives 6, 7a-c, 8a,b, 9a,b and 10-12 were synthesized as modified pyrazoloquinolinone analogs (PQs) and evaluated for their ability to inhibit radioligand to central and peripheral benzodiazepin

3-Substituted 7-phenyl-pyrroloquinolinones show potent cytotoxic activity in human cancer cell lines

Gasparotto, Venusia,Castagliuolo, Ignazio,Ferlin, Maria Grazia

, p. 5509 - 5513 (2007)

A novel series of 3-alkyl-substituted 7-phenyl-3H-pyrrolo[3,2-f]quinolin-9- ones (7-PPyQs) was synthesized with the aim to optimize the cytotoxic activity of recently identified PPyQs, promising inhibitors of tubulin polymerization. All compounds inhibited the growth of 11 human tumor cell lines at submicromolar concentrations as well as two human resistant cancer sublines, A549-T12 and A549-T24. FACS analysis indicated that all compounds caused significant arrest of the A549 cell cycle in G2/M phase at 0.1 and 1 μM and a good correlation between the cytotoxicity IC50 and their ability to block the cell cycle was observed.

Discovery of N-(1-(3-fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B

Elkamhawy, Ahmed,Paik, Sora,Kim, Hyeon Jeong,Park, Jong-Hyun,Londhe, Ashwini M.,Lee, Kyeong,Pae, Ae Nim,Park, Ki Duk,Roh, Eun Joo

, p. 1568 - 1580 (2020)

Herein, two new series of N-substituted indole-based analogues were rationally designed, synthesized via microwave heating technology, and evaluated as noteworthy MAO-B potential inhibitors. Compared to the reported indazole-based hits VI and VII, compounds 4b and 4e exhibited higher inhibitory activities over MAO-B with IC50 values of 1.65 and 0.78?μM, respectively. When compared to the modest selectivity index of rasagiline (II, a well-known MAO-B inhibitor, SI > 50), both 4b and 4e also showed better selectivity indices (SI > 60 and 120, respectively). A further kinetic evaluation of the most potent derivative (4e) displayed a competitive mode of inhibition (inhibition constant (K i)/MAO-B = 94.52 nM). Reasonable explanations of the elicited biological activities were presented via SAR study and molecular docking simulation. Accordingly, the remarkable MAO-B inhibitory activity of 4e (N-(1-(3-fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide), with its selectivity and competitive inhibition, advocates its potential role as a promising lead worthy of further optimization.

A general palladium-catalyzed animation of aryl halides with ammonia

Schulz, Thomas,Torborg, Christian,Enthaler, Stephan,Schaeffner, Benjamin,Dumrath, Andreas,Spannenberg, Anke,Neumann, Helfried,Boerner, Armin,Beller, Matthias

, p. 4528 - 4533 (2009)

A study was conducted to demonstrate palladium(Pd)-catalyzed amination of aryl halides with ammonia. The active catalyst was formed in situ from Pd(OAc)2, along with air- and moisture stable phosphines as pre-catalysts. It was found that the productivity of the catalyst system was similar to that of competitive Pd and phosphine systems. It was demonstrated that the novel electron-rich sterically demanding phosphine ligand was unable to be displaced from the palladium by ammonia to a significant extent, which prevented the deactivation of the catalyst by the ligand. It was also demonstrated that the Pd-catalyzed animation worked at ambient pressure. It was observed that the optimized system showed an excellent substrate scope including deactivated, electron-neutral, and activated halides, o-, m- p-substituted substrates, aryl chlorides, and heterocycles.

Chemoselective transfer hydrogenation of nitroarenes by highly dispersed Ni-Co BMNPs

Zhang, Jia-Wei,Lu, Guo-Ping,Cai, Chun

, p. 25 - 29 (2016)

Highly dispread Ni-Co bimetallic nanoparticles (Ni-Co BMNPs) are synthesized and applied as an efficient catalyst in the chemoselective transfer hydrogenation of nitroarenes (CTH) using hydrazine hydrate as the hydrogen donor. The BMNPs can efficiently catalyze the reduction reaction without any additives under mild conditions with high TOF. Significantly higher activity is achieved when compared with corresponding single-component catalysts, optimal composition of the Ni-Co BMNPs was screened which was proved to be crucial in both the selectivity and yields. Excellent performance of Ni-Co BMNPs can be ascribed to the improved dispersion of active sites on the BMNPs surface (compared with Ni NPs) and the electron transfer from cobalt to nickel.

Electroreduction of 1-methyl 5-nitroindole, 5-nitrobenzofurane, and 5-nitrobenzothiophene in acidic and basic hydroorganic media: Generation and trapping of iminoquinone-type intermediates and electrosynthesis of ring-substituted amino derivatives

Bouchard, Luc,Marcotte, Ian,Chapuzet, Jean Marc,Lessard, Jean

, p. 1108 - 1118 (2003)

Preparative electrolysis of 1-methyl-5-nitroindole (1b, X = NCH 3), 5-nitrobenzofurane (1c, X = O), and 5-nitrobenzothiophene (1d, X = S) at Hg, in acidic hydromethanolic media, leads to the formation of the corresponding 4-substituted amino derivatives 5, which result from the 100% regioselective addition to iminoquinone-type intermediate 4 of methanol or of any other good nucleophile present in the electrolytic solution. In acidic medium, the iminoquinonium intermediates 4b and 4c were trapped in a cycloaddition reaction with cyclopentadiene added to the electrolysis medium. The regiochemistry of the nucleophilic addition is discussed in light of AM1 calculations.

Direct C-H bond arylation: Selective palladium-catalyzed C2-arylation of N-substituted indoles

Lane, Benjamin S.,Sames, Dalibor

, p. 2897 - 2900 (2004)

(Equation Presented) We present a new, practical method by which N-substituted indoles may be selectively arylated in the C2-position with good yields, low catalyst loadings, and a high degree of functional group tolerance. Our investigation found that two competitive processes, namely, the desired cross-coupling and biphenyl formation, were operative in this reaction. A simple kinetic model was formulated that proved to be instructive and provided useful guidelines for reaction optimization; the approach described within may prove to be useful in other catalytic cross-coupling processes.

Iridium-catalyzed transfer hydrogenation of nitroarenes to anilines

Chen, Shujie,Lu, Guoping,Cai, Chun

, p. 5360 - 5365 (2015)

A simple and general homogeneous catalyst system composed of commercially available [Ir(cod)Cl]2 and 1,10-phenanthroline has been developed for the selective transfer hydrogenation of nitroarenes to anilines. It utilized the readily accessible 2-propanol as a hydrogen donor and had wide substrate scope. A careful mechanistic investigation through real-time detection and a series of controlled experiments with possible intermediates was also carried out, which showed that the transformation proceeds via both phenylhydroxylamine and azobenzene intermediates and the reduction of hydrazobenzene leading to aniline might be the rate-determining step.

Synthesis and in Vitro Evaluation of Novel 5-Nitroindole Derivatives as c-Myc G-Quadruplex Binders with Anticancer Activity

Nimbarte, Vijaykumar D.,Wirmer-Bartoschek, Julia,Gande, Santosh L.,Alshamleh, Islam,Seibert, Marcel,Nasiri, Hamid Reza,Schnütgen, Frank,Serve, Hubert,Schwalbe, Harald

, p. 1667 - 1679 (2021/03/24)

Lead-optimization strategies for compounds targeting c-Myc G-quadruplex (G4) DNA are being pursued to develop anticancer drugs. Here, we investigate the structure-activity- relationship (SAR) of a newly synthesized series of molecules based on the pyrrolidine-substituted 5-nitro indole scaffold to target G4 DNA. Our synthesized series allows modulation of flexible elements with a structurally preserved scaffold. Biological and biophysical analyses illustrate that substituted 5-nitroindole scaffolds bind to the c-Myc promoter G-quadruplex. These compounds downregulate c-Myc expression and induce cell-cycle arrest in the sub-G1/G1 phase in cancer cells. They further increase the concentration of intracellular reactive oxygen species. NMR spectra show that three of the newly synthesized compounds interact with the terminal G-quartets (5′- and 3′-ends) in a 2 : 1 stoichiometry.

Novel heteroaryl amide derivatives as MAO-B inhibitors and pharmaceutical compositions for preventing, ameliorating or treating neurodegenerative diseases comprising the same

-

, (2021/04/06)

A novel heteroaryl amide derivative compound useful as MAO-B inhibitors. The present invention relates to a compound selected from a pharmaceutically acceptable salt thereof, a hydrate thereof, or a stereoisomer thereof, and a pharmaceutical composition comprising the compound as an active ingredient for preventing, alleviating, or treating neurodegenerative diseases such MAO as B's disease, 's disease, 's disease, and the like.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 102308-97-4